How did our management miss the mark so badly.

This should have been a better place to work than it is. What has made it go so wrong?

 

What are your complaints? It’s not perfect but no place is! Goals are and always have been way off the mark but they will figure it out when people continue to leave because of money!

 

This place has been smoke and mirrors since day one. Lots of great talk but absolutely no plan and poor leadership. The landscape for Pharma and especially Pain is a shrinking mess but until the well is completely dry most of us will trudge forward. It beats roofing houses!

 

How can they pay more?
We lose $100M per quarter?
Have you seen the sales numbers?

 

It's only a matter of time. Collegium cannot continue to lose the huge amount of cash each quarter that they are losing. Listen to the earnings calls. Great product, but poor leadership. Too weak to play in the pharma industry let alone in the pain space. Keep rearranging the deck chairs all you want, the Titanic is still going to go down.

 

you are kidding right? relative to other companies in their first couple years of launching a drug, collegium barely losses any money. I think it was ~$15-18 million in the fourth quarter on $11 million in sales. the cash burn should be a lot less in the first quarter with XT volumes up so much the last few months with sales totaling around $15-$20 million. and it will continue to narrow the rest of the year as XT continues to grow. company has over $100 million in cash in reserve and no debt. you can certainly find pharma companies burning through far far far more cash than little collegium. man, some guys here complain way too much. you dont know how good you have it. go ask guys at Egalet how they are doing.

 

I went and asked the guys at Egalet as you requested. They told me Collegium still sucks balls.

 

Problem might be that management replies to stupid threads on cafepharma. See above.

 

Well let's go to the video tape. Egalet filled ~375 scripts for Arymo last week while Collegium filled ~5,500. So if we are comparing these two new pain-focused companies, i think the answer is clear.

Full disclosure i don't work for either of these companies. Just a watchful observer who wanted to chime in.

 

There is your answer...... management is monitoring cafepharma. Like middle school.

 

Rat boy, you still bumming you lazy fired retarded lump of shit ?

 

Don't work here, but recently interviewed for an open slot.

The manager I interviewed with was open, honest and smart. I backed out before an offer was made, but the mix of Xtampza and Nucynta is a winning one, especially in this opioid environment. The big question will be if opioids as a treatment option for acute or chronic pain will continue to decline in volume. The marketplace drop from 2016-2017 was approximately 12%, which will hurt any company selling branded options.

The non-opioid options are increasing, and their success will be m/c coverage, like anything else.

Good luck to you guys.

 

i.e.you didn't get the offer because you dont have what it takes to sell C2 products ace!

 

I didn't leave because of the money. I left due to the poor leadership from the top down as well as the culture. It was not the adult pharma company I thought it was when I joined. I do wish the best for all who remain, and Xtampza is a kick ass product (for an opioid), but the grass is greener other places. There are plenty of companies where specialty reps are treated like adults and not like PCP reps. PS The reason the company is losing so much money is because the company is giving payers such deep discounts. It can't last forever.

 

You mean seek Me2 right? Are you defending Collegium because their medical paid for your mom’s failed gastric bypass? Defend the fact you’re a loser, not this company. I bet you look smarter when you keep your mouth closed...on my balls.

 

Pharma is Pharma....this place is like everywhere else.

 

+1

 

The biggest problem is that they brought in new management and then left the unethical people in the middle. Originally, the upper management was like a big gaping hole where ethics were concerned. If you got prescriptions, and they knew it, and they didn't get assigned to you, they just left it that way and paid the wrong people. They didn't care. Then the "president's club winners" would win, and jump ship immediately after. Management thought we didn't know. We all knew, and could do nothing about it. Joe C. came from a company that truly believes in getting their people paid for their work. It gave hope that they would change. So far, no change at all.